Filing Details
- Accession Number:
- 0001181431-11-018573
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-03-17 08:00:26
- Reporting Period:
- 2011-02-21
- Filing Date:
- 2011-03-17
- Accepted Time:
- 2011-03-17 08:00:26
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1103021 | Biodelivery Sciences International Inc | BDSI | Pharmaceutical Preparations (2834) | 352089858 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1301715 | A Mark Sirgo | C/O Biodelivery Sciences Intl, Inc. 801 Corporate Center Drive, Suite 210 Raleigh NC 27607 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2011-03-15 | 2,130 | $3.30 | 829,162 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2011-03-15 | 900 | $3.28 | 830,062 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option | Acquisiton | 2011-02-21 | 22,369 | $0.00 | 22,369 | $3.55 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 22,369 | 2021-02-25 | No | 4 | A | Direct |
Footnotes
- One third of the options granted herein will vest and be exercisable on each of the following dates, February 25, 2012, February 25, 2013 and February 25, 2014, subject to the condition that the reporting person is employed by the Issuer on each of the respective dates.
- Not applicable. Such options were granted by Issuer's Board of Directors as compensation for serving as President and Chief Executive Officer.
Billionaire Hedge Funds
